These trying times send more to medical studies
The News Review:
- These trying times send more to medical studies
- Researchers induce formation of new blood vessels using stem cells …
- Cancer Researchers In Bakersfield Seek Volunteers
- Philip Hogg awarded NSW’s top cancer research gong
- Fraudulent Trials Behind Asthma Drugs Cited
- Budget a lost chance for reform
- CBU gets $1.21 million for international research
These trying times send more to medical studies
Boston Herald
The number of healthy people signing up for the Research Study Volunteer Program (or RSVP for Health) a database of medical trials at Massachusetts General and Brigham & Women’s hospitals jumped 6. 9 percent in the first five months of the year compared to the same period a year ago. “If that continues we’re going to be up over 16. 5 percent by the end of the year” said Kay Ryan clinical research operations director for Partners HealthCare which administers the RSVP program.
Researchers induce formation of new blood vessels using stem cells …
Insciences rganisation
They are working to understand the mechanism behind the homing behavior observed in the stem cells. “We have found that the key is a class of molecules called chemokines” Nolta explained who along with her colleagues is preparing to publish additional work showing how stem cells are able to find their way to areas of low oxygen in the body. “We know that if we eliminate specific molecules the stem cells lose their homing abilities” she said. UC Davis is playing a leading role in stem cell research with more than 125 scientists and physicians currently working on a variety of stem cell investigations at campus locations in both Davis and Sacramento.
Related from Worlddiamondcongress2008: Cellular Discovery May Lead To Targeted Treatment For Rare Form f …
Cancer Researchers In Bakersfield Seek Volunteers
TurnTo23.com
“The design of this clinical trial is based on preclinical and early clinical work done in UCLA laboratories. We look forward to investigating the additional benefit to patients of combining these two treatments with chemotherapy in the treatment of early breast cancer. “The study is being done at multiple sites in California and nationwide that are part of Translational ncology Research International (TRI) a nonprofit clinical research organization collaborating with UCLA’s Jonsson Comprehensive Cancer Center. TRI is dedicated to developing new therapies for cancer. For information about the study at Comprehensive Blood & Cancer Center in Bakersfield call Dr. Ravi Patel at (661) 862-7119 or email ddavis@cbccusa.
Philip Hogg awarded NSW’s top cancer research gong
Australian Life Scientist
ther award recipients at the 2009 Cancer Institute NSW Premier’s Awards for utstanding Cancer Researchutstanding Cancer Research Fellow: Professor Richard Scolyer whose research into melanoma at Royal Prince Alfred Hospital is aimed at improving the accuracy of diagnosis and treatment. utstanding Cancer Research Scholar: Emily Colvin of the Garvan Institute of Medical Research for her research into pancreatic cancer. Innovation in Cancer Clinical Trials: Border Medical ncology Clinical Trials Unit Albury for their commitment to providing access to clinical trials by developing an innovative model of clinical research in a regional setting. Excellence in Translational Cancer Research: Sydney Melanoma Unit for their groundbreaking and internationally recognised research into melanoma and translating their findings into clinical practice. More about Garvan Institute of Medical Research GlaxoSmithKline Royal Prince Alfred Hospital University of NSW Comments Post new comment Login or register to link comments to your user profile or you may also post a comment without being logged in. Subject: Comment:.
Fraudulent Trials Behind Asthma Drugs Cited
Dissident Voice
This “safety last” policy is a expected outgrowth of the 1992 Prescription Drug User Fee Act (PDUFA) that allows drug companies to pay the FDA to accelerate approvals says Davidson. “It takes time to obtain a properly administered formal informed consent with full disclosure of risks and benefits and that slows study-subject recruitment and ultimately delays the time to obtain market approval from FDA” says Davidson. “It is virtually certain that there have been deaths of US citizens because of the fraudulent or seriously-flawed clinical research PDUFA encourages. Nor is FDA likely to revoke expedited market approvals because that would be tantamount to admitting that they ‘goofed. ’” When presented with 51 allegations of Vivra’s medical wrongdoing in 2000 the Arizona Board of Medical Examiners also did not act calling the evidence “insufficient to support a violation” of Arizona Revised Statutes. This is not the first time bogus pay-to-play research which risks study subjects and the public’s health has surfaced. Recently Alabama physician Anne Kirkman Campbell began serving a sentence in a federal prison in Lexington KY for clinical trials she conducted of the controversial antibiotic Ketek linked to liver failures and deaths.
Budget a lost chance for reform
The Australian
Faced with these same challenges other countries are headed down the path of reform. Britain has a new phase of investment in regionally responsive health authorities and more competitive providers of care. In the US the bama administration is using its stimulus package to drive health insurance reform and bankroll big new investments in basic and clinical research. The Netherlands is implementing a more radical system of competing national insurance systems to drive innovation in its public and private sectors. In Australia Health Minister Nicola Roxon has stated clearly her preference for preventative health care primary care teams and child and youth services. Kevin Rudd has promised to take over health care if the states continue to neglect their responsibilities. As was the case with the 2008 budget however Treasury and the Finance Department rather than health reformers are driving the agenda.
CBU gets $1.21 million for international research
Bizjournals.com
The renewal of this grant will fund the MHIRT program with over $1 million until 2014. The program is a collaboration between CBU St. Jude Children’s Research Hospital and.
Written by admin on May 24th, 2009 with
no comments.
Read more articles on News.